Activation of circulating monocytes by low-density lipoprotein-a risk factor for osteoarthritis?

Area of Science:

• Immunology
• Metabolic Syndrome
• Osteoarthritis Pathogenesis

Background:

• Synovial macrophages are central to osteoarthritis (OA) pathology.
• An M1-like macrophage phenotype contributes to chronic synovial inflammation in OA.
• Metabolic syndrome (MetS) components, such as dyslipidemia, influence macrophage phenotype and function, potentially linking MetS to OA.

Purpose of the Study:

• To explore the origins and heterogeneity of synovial macrophages in OA.
• To investigate the role of monocyte-derived macrophages in promoting a pro-inflammatory phenotype shift.
• To examine how metabolic factors influence monocyte function and OA development.

Main Methods:

• Review of recent studies on synovial macrophage origins and heterogeneity.
• Analysis of metabolic syndrome components' impact on macrophage phenotype.
• Exploration of innate immune training concepts in OA context.

Main Results:

• Monocyte-derived macrophages, rather than yolk-sac derived ones, are implicated in driving pro-inflammatory shifts.
• Metabolic factors like low-density lipoprotein can 'train' circulating monocytes.
• This training enhances monocyte responsiveness to inflammatory stimuli, preceding synovial infiltration.

Conclusions:

• Monocyte-derived macrophages play a critical role in OA-associated inflammation.
• Innate immune training of monocytes by metabolic factors is a potential mechanism in OA.
• These findings suggest novel therapeutic targets involving macrophages and metabolic factors for OA treatment.